Delivery Order SPE2DB20D2014-SPE2DB25FB73R
- Not listed
- The Defense Logistics Agency awarded a $1,079.01 delivery order to AmerisourceBergen Drug Corp on December 9, 2025, for the supply of Trulicity 0.75 mg/0.5 ml pen injections. This non-competitive, firm fixed-price contract represents a child delivery order issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at approximately $1 billion through December 2026. The product will be delivered to AmerisourceBergen's facility in Conshohocken,...
- The Defense Logistics Agency awarded a $4,222.57 firm fixed-price delivery order to AmerisourceBergen Drug Corp for the supply of Trulicity 1.5 mg/0.5 mL pen injectors (0.5 mL units) on April 24, 2025, with an ultimate completion date of April 25, 2025. This non-set-aside competitive award represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999 and extending through December 2026. The...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a $2,717.94 delivery order on August 15, 2025, for the supply of Trulicity 1.5 mg/0.5 ml pen injections, a diabetes medication. This firm fixed-price contract, with an ultimate completion date of August 18, 2025, represents a child delivery order under a larger contract vehicle and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The award was made through open competition with no...
- The Defense Logistics Agency awarded a $2,402.40 firm fixed price delivery order to AmerisourceBergen Drug Corp for the supply of Trulicity 0.75 mg/0.5 ml pen injections on July 18, 2025, with completion targeted for July 21, 2025. This non-set-aside competitive award represents a child delivery order issued under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), which is valued at $999,999,999.00 and extends through December 2026. The...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a $1,801.80 delivery order on August 20, 2025, for the supply of Trulicity 1.5 mg/0.5 mL pens in 0.5 mL quantities. This competitively awarded, firm fixed-price contract with an ultimate completion date of August 21, 2025, represents a child delivery order executed under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical. The pharmaceutical product will be performed from the contractor's...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a $1,831.68 firm fixed-price delivery order on August 25, 2025, for Trulicity 1.5 mg/0.5 mL pens. This contract represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through December 2026. The delivery order involves no set-aside designation and was competitively awarded. Performance will be completed...
- The Defense Logistics Agency awarded a delivery order valued at $2,552.03 to AmerisourceBergen Drug Corp for the supply of Trulicity 1.5 mg/0.5 ml pen injections on December 31, 2025, with completion targeted for January 2, 2026. This competitively awarded, non-set-aside contract operates under firm fixed pricing and represents a child delivery order issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical. The pharmaceutical will be delivered...
- The Defense Logistics Agency awarded a $1,878.10 firm fixed-price delivery order to AmerisourceBergen Drug Corp for Trulicity 1.5 mg/0.5 mL pen injectors (0.5 mL units) on August 19, 2025, with completion scheduled for August 20, 2025. This competitive award, with no set-aside designation, represents a child delivery order under AmerisourceBergen's substantial Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at approximately $1 billion through December 2026. The...
- The Defense Logistics Agency awarded a $3,182.51 delivery order to AmerisourceBergen Drug Corp for Trulicity 1.5 mg/0.5 ml pen (0.5 ml) on June 6, 2025, with completion expected by June 9, 2025. This firm fixed price, non-set-aside contract represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX and valued at $999,999,999.00 through December 2026. The pharmaceutical distributor, headquartered in...
- The Defense Logistics Agency awarded a $1,651.65 delivery order to AmerisourceBergen Drug Corp on November 5, 2025, for the supply of Trulicity 1.5 mg/0.5 mL pen injections. This firm fixed price, non-set-aside contract is a delivery order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (designated SPE2DX), valued at $999,999,999.00 and extending through December 2026. The work will be performed at AmerisourceBergen's corporate office location in...
- SPE2DB20D2014Indefinite Delivery Contract
- SPE2DB20D2014-SPE2DB25FB73RDelivery Order
The Defense Logistics Agency awarded a $2,997.45 firm fixed-price delivery order to AmerisourceBergen Drug Corp on April 24, 2025, for the supply of Trulicity 1.5 mg/0.5 ml pen injections. This non-set-aside contract represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00 and extending through December 2026. The delivery order is scheduled for completion by April 25, 2025, with performance to occur at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. As a major pharmaceutical distributor and critical federal medical supplier, AmerisourceBergen Drug Corp serves the Defense Health Agency, U.S. Coast Guard, and other government healthcare systems through its comprehensive DLA pharmaceutical support vehicle. The underlying IDC enables AmerisourceBergen to supply an extensive portfolio of pharmaceutical products and medical supplies, including specialty medications, brand-name and generic drugs, vaccines, and medical devices across multiple therapeutic domains to support military healthcare programs globally. This delivery order for diabetes medication reflects the company's ongoing role in fulfilling essential pharmaceutical commodities for federal medical supply chains.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $3.0k | 4/24/25 |